PV Bulletin

QRD Guidance on Abbreviations and Pictograms for Veterinary Medicines

New regulatory guidance issued regarding the use of abbreviations and pictograms on packaging for veterinary medicinal products.

Primary source: français

PV Impact Brief

Urgency: HighConfidence: high

What changed

The QRD guidance specifies that from 11 May 2024, new abbreviations and pictograms can replace existing labeling information on veterinary medicinal products.

Why it matters

This guidance ensures proper identification and comprehension of veterinary medicines by users and facilitates compliance with EU regulations, ultimately enhancing safety and efficacy in the veterinary medicine sector.

Action needed

Marketing authorization holders (MAHs) must review and potentially update their product labeling to align with the new regulations by 11 April 2029 for products authorized before 11 May 2024.

Relevant for
Regulatory Intelligence Lead
Processes impacted
Signal Management
Owner

Regulatory Intelligence Lead

Review cadence

Quarterly monitoring recommended until compliance deadline.

Evidence and confidence

Confidence: highSource updated: Aug 26, 2026

Full briefing

Practical implication

Marketing authorization holders (MAHs) must review and potentially update their product labeling to align with the new regulations by 11 April 2029 for products authorized before 11 May 2024.

The European Medicines Agency (EMA) has introduced guidance pertaining to the implementation of adopted abbreviations and pictograms on the packaging of veterinary medicinal products authorized through various EU procedures including centralised, mutual recognition, decentralized, and national procedures. This guidance outlines the transitional period and specifics for compliance, including dates and applicability for new marketing authorisations.

What changed: The QRD guidance specifies that from 11 May 2024, new abbreviations and pictograms can replace existing labeling information on veterinary medicinal products.

Why it matters: This guidance ensures proper identification and comprehension of veterinary medicines by users and facilitates compliance with EU regulations, ultimately enhancing safety and efficacy in the veterinary medicine sector.

Practical implication: Marketing authorization holders (MAHs) must review and potentially update their product labeling to align with the new regulations by 11 April 2029 for products authorized before 11 May 2024.

View original source

  • Source: EMA - What's new RSS
  • Published at source: 2026-08-26T00:00:00.000Z
  • Discovered by monitor: 2026-08-26T22:30:49.203Z

Published from the regulator source ingestion pipeline after PV impact triage.

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicUK Health Security Agency · UK · Updated Sep 7, 2026

Low Flu Vaccination Rates Among Primary School Children

Urgency: High

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

Signal ManagementPV Quality Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: PV Quality Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Recall of Gore Viabahn Endoprosthesis with Bioactive Heparin Coating

Urgency: High

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward